Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2018 Oct 11;13(10):e0205506.
doi: 10.1371/journal.pone.0205506. eCollection 2018.

Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study

Affiliations
Multicenter Study

Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study

Luca Navarini et al. PLoS One. .

Abstract

Introduction: In patients with psoriatic arthritis (PsA) an increased cardiovascular (CV) risk has been observed. Recently, a EULAR taskforce suggested to use a multiplication by the factor of 1.5 of CV risk algorithms in patients with inflammatory arthritis. This study aims to evaluate the performance of five original and adapted according to EULAR recommendations CV risk algorithms in PsA: SCORE, CUORE, Framingham Risk Score (FRS), QRISK2, and Reynold's Risk Score (RRS).

Methods: Prospectively collected data from two Italian cohorts were used. Discriminatory ability for CV risk prediction was evaluated by the area under the ROC curves. Calibration between predicted and observed events was assessed by Hosmer-Lemeshow (HL) tests. Sensibility and specificity were calculated for low-to-intermediate and intermediate-to-high risk cut-offs.

Results: One hundred fifty-five patients were enrolled with an observation of 1550 patient/years. Area under the ROC were 0.7679 (95% CI 0.64768 to 0.88812), 0.864 (95% CI 0.79675 to 0.93278), 0.7575 (95% CI 0.65784 to 0.85708), 0.8660 (95% CI 0.79428 to 0.93772), and 0.7183 (95% CI 0.57795 to 0.85862) for SCORE, CUORE, FRS, QRSIK2, and RRS, respectively. HL tests demonstrated poor model fit (p<0.05) for SCORE, CUORE, and RRS. Discriminative ability and calibration were not improved by adaption of the algorithms according to EULAR recommendations. Up to 80% of CV events occurred in patients at "low risk" and up to 93% of CV events in patients at "low-intermediate risk".

Conclusions: Adaption of the CV risk algorithms according to EULAR indications did not provide improvement in discriminative ability and calibration in patients with PsA.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. ROC curves for the different original algorithms.
Areas under the curve (AUC)-values (95% CI) are 0.7679 (95% CI 0.64768 to 0.88812), 0.864 (95% CI 0.79675 to 0.93278), 0.7575 (95% CI 0.65784 to 0.85708), 0.8660 (95% CI 0.79428 to 0.93772), and 0.7183 (95% CI 0.57795 to 0.85862) for SCORE (A), CUORE (B), FRS (C), QRSIK2 (D), and RRS (E), respectively.
Fig 2
Fig 2. ROC curves for the different algorithms adapted according to EULAR indications.
Areas under the curve (AUC)-values (95% CI) are 0.7679 (95% CI 0.64768 to 0.88812), 0.8648 (95% CI 0.79675 to 0.93278), 0.7584 (95% CI 0.65889 to 0.85782), 0.8664 (95% CI 0.79452 to 0.93834), and 0.7183 (95% CI 0.57795 to 0.85862) for SCORE*1.5 (A), CUORE*1.5 (B), FRS*1.5 (C), QRISK2-RA (D), and RRS*1.5 (E), respectively.
Fig 3
Fig 3. Observed versus predicted risk.
Observed (dark grey bars) vs predicted (light grey bars) CV events (%) in deciles, sextiles, and septiles for SCORE (A), SCORE*1.5 (B), CUORE (C), CUORE*1.5 (D), FRS (E), FRS*1.5 (F), QRISK2 (G), QRISK2-RA (H), RRS (I), and RRS*1.5 (L).

References

    1. Ritchlin CT, Colbert RA, Gladman DD. Psoriatic Arthritis. N Engl J Med. 2017;376(10):957–70. 10.1056/NEJMra1505557 . - DOI - PubMed
    1. Yim KM, Armstrong AW. Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms. Rheumatology international. 2017;37(1):97–105. Epub 2016/05/26. 10.1007/s00296-016-3487-2 . - DOI - PubMed
    1. Costa L, Caso F, D'Elia L, Atteno M, Peluso R, Del Puente A, et al. Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study. Clinical rheumatology. 2012;31(4):711–5. Epub 2011/11/25. 10.1007/s10067-011-1892-1 . - DOI - PubMed
    1. Sobchak C, Eder L. Cardiometabolic Disorders in Psoriatic Disease. Current rheumatology reports. 2017;19(10):63 Epub 2017/08/28. 10.1007/s11926-017-0692-2 . - DOI - PubMed
    1. Ramonda R, Lo Nigro A, Modesti V, Nalotto L, Musacchio E, Iaccarino L, et al. Atherosclerosis in psoriatic arthritis. Autoimmunity reviews. 2011;10(12):773–8. Epub 2011/06/21. 10.1016/j.autrev.2011.05.022 . - DOI - PubMed